>>Overview of scientific publications : Prof. Andr�� EFIRA

Andr�� EFIRA

1: Stamatopoulos B, Smith T, Crompot E, Pieters K, Clifford R, Mraz M, Robbe P, Burns A, Timbs A, Bruce D, Hillmen P, Meuleman N, Mineur P, Firescu R, Maerevoet M, De Wilde V, Efira A, Philipp J, Verhasselt B, Offner F, Sims D, Heger A, Dreau H, Schuh A. The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study. Clin Cancer Res. 2018 Oct 15;24(20):5048-5057. doi: 10.1158/1078-0432.CCR-18-0133. Epub 2018 Jun 26.
>PubMed

2: Morissens M, Castro Rodriguez J, Azerad MA, Besse-Hammer T, Efira A. Added value of speckle tracking in the evaluation of cardiac function in patients with sickle cell disease. Br J Haematol. 2018 Jun 19. doi: 10.1111/bjh.15398. [Epub ahead of print]
>PubMed

3: Latifyan S, Vansteelandt C, Lecomte S, Efira A. [Tamoxifen induced thromboembolic events in breast cancer. Some possible mechanisms]. Rev Med Brux. 2017;38(6):494-500. French.
>PubMed

4: Sins JWR, Fijnvandraat K, Rijneveld AW, Boom MB, Kerkhoffs JH, van Meurs AH, de Groot MR, Heijboer H, Dresse MF, L PQ, Hermans P, Vanderfaeillie A, Van Den Neste EW, Benghiat FS, Kesse-Adu R, Delannoy A, Efira A, Azerad MA, de Borgie CA, Biemond BJ. Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial. Br J Haematol. 2017 Jun 23. doi: 10.1111/bjh.14809. [Epub ahead of print]
>PubMed

5: Van Obbergh F, Knoops L, Devos T, Beguin Y, Graux C, Benghiat F, Kargar-Samani K, Bauwens D, Efira A, Dubois C, Springael C, Montfort L, Connerotte T, Capron A, Delannoy A, Wallemacq P. The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clin Biochem. 2017 May;50(7-8):452-454. doi: 10.1016/j.clinbiochem.2016.12.006. Epub 2016 Dec 22.
>PubMed

6: L PQ, Gulbis B, Dedeken L, Dupont S, Vanderfaeillie A, Heijmans C, Huybrechts S, Devalck C, Efira A, Dresse MF, Rozen L, Benghiat FS, Ferster A. Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment. Pediatr Blood Cancer. 2015 Nov;62(11):1956-61. doi: 10.1002/pbc.25608. Epub 2015 Jul 14.
>PubMed

7: Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen K, Noens L, Van Steenweghen S, Lemmens J, Pierre P, D'hondt R, Ferrant A, Deeren D, Van De Velde A, Wynendaele W, Andr M, De Bock R, Efira A, Breems D, Deweweire A, Geldhof K, Pluymers W, Harrington A, MacDonald K, Abraham I, Ravoet C. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes. Leuk Res. 2014 May;38(5):557-63. doi: 10.1016/j.leukres.2014.02.003. Epub 2014 Feb 14.
>PubMed

8: Efira A, Azerad MA. [Refractory anemias]. Rev Med Brux. 2013 Sep;34(4):323-7. Review. French.
>PubMed

9: El Kenz H, Efira A, Le PQ, Thiry C, Valsamis J, Azerad MA, Corazza F. Transfusion support of autoimmune hemolytic anemia: how could the blood group genotyping help? Transl Res. 2014 Jan;163(1):36-42. doi: 10.1016/j.trsl.2013.09.007. Epub 2013 Oct 9.
>PubMed

10: Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, D'Haens G, Paesmans M, Peeters M, Efira A, Humblet Y. A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer. Acta Gastroenterol Belg. 2012 Mar;75(1):14-21.
>PubMed

11: Debaugnies F, Azerad MA, Noubouossi D, Rozen L, Hemker HC, Corazza F, Efira A, Demulder A. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay. Thromb Res. 2010 Dec;126(6):531-5. doi: 10.1016/j.thromres.2010.09.002. Epub 2010 Sep 25.
>PubMed

12: Mendes da Costa P, Efira A. [May still in 2010 a surgeon decide alone to operate a digestive cancer?]. Rev Med Brux. 2009 Nov-Dec;30(6):549-54. French.
>PubMed

13: Civrilli K, Damry N, Stepp R, Efira A, Mathieu J. Bilateral adrenal myelolipomas. JBR-BTR. 2008 May-Jun;91(3):90-1.
>PubMed

14: Schanden L, Roufosse F, de Lavareille A, Stordeur P, Efira A, Kenns B, Cogan E, Goldman M. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 2000 Dec 15;96(13):4285-92.
>PubMed

15: Efira A. [What is the role of internal medicine in the collective of a general hospital?]. Acta Clin Belg. 2000 Jul-Aug;55(4):199-204. French.
>PubMed

16: Roufosse F, Schanden L, Sibille C, Willard-Gallo K, Kennes B, Efira A, Goldman M, Cogan E. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol. 2000 Jun;109(3):540-8.
>PubMed

17: Roufosse F, Schanden L, Sibille C, Kennes B, Efira A, Cogan E, Goldman M. T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood. 1999 Aug 1;94(3):994-1002.
>PubMed

18: Plein D, Van Camp G, Efira A, Brunet A, Vandenbossche JL. Intracardiac thrombi associated with antiphospholipid antibodies. J Am Soc Echocardiogr. 1996 Nov-Dec;9(6):891-3.
>PubMed

19: des Grottes JM, Bouvry P, Cantinieaux B, Efira A. [A case of thrombotic thrombopenic purpura. Literature review]. Rev Med Brux. 1996 Jun;17(3):136-9. Review. French.
>PubMed

20: Postelmans L, Verougstraete C, Libert J, Efira A, Caspers-Velu L. [Intravenous corticosteroid megadose treatment in ocular Behet disease]. Bull Soc Belge Ophtalmol. 1996;262:95-103. French.
>PubMed

21: Volz A, Renard N, Alame T, Efira A. [Churg-Strauss syndrome: personnel case report and literature review]. Rev Med Brux. 1994 Mar-Apr;15(2):76-9. Review. French.
>PubMed

22: Cauchie P, Delwiche F, Efira A, Vincken W, Volckaert A, Decaux G. Tuberculosis: cause of death in Brussels. Ann Med Interne (Paris). 1988;139(2):132-3.
>PubMed

!Data extracted directly from PubMed and filtered to reduce the risk of homonymy. You can remove the "Brugmann" filter to enlarge results.

>>More about Prof. Andr�� EFIRA.